top of page
logo-big.jpg

May 9, 2018

Initial phase I/IIa trial results of an autologous tumor lysate, particle-loaded, dendritic cell (TLPLDC) vaccine in patients with solid tumors

Vaccine | Herbert, et al.

READ MORE

February 7, 2018

Tumor lysate particle loaded dendritic cell vaccine: preclinical testing of a novel personalized cancer vaccine

Immunotherapy | Hardin et al.

READ MORE

June 8, 2019

New List IAmerican Society of Clinical Oncology - Clinical efficacy of vaccination with the autologous tumor lysate particle loaded dendritic cell (TLPLDC) vaccine in metastatic melanomatem

Journal of Clinical Oncology | Hickerson, et al.

READ MORE

June 16, 2018

American Society of Clinical Oncology - Prospective, randomized, double-blind, placebo controlled, Phase IIb trial of the TLPLDC vaccine to prevent recurrence in resected Stage III or IV melanoma patients

​

READ MORE

PUBLICATIONS & PRESENTATIONS

CONTACT US

We would love to hear from you. Tell us a little about yourself and we will reach out.

Thanks for your message!

logo-small.jpg

Elios Therapeutics, LLC
​111 Smith Hines Road, Suite E

Greenville, SC 29607

bottom of page